MAGNESIUM Drug Patent Profile
✉ Email this page to a colleague
When do Magnesium patents expire, and when can generic versions of Magnesium launch?
Magnesium is a drug marketed by Santarus, B Braun Medical Inc, Exela Pharma, Fresenius Kabi Usa, Hospira, Baxter Hlthcare Corp, Hq Spclt Pharma, Mylan Labs Ltd, Amneal, Gland Pharma Ltd, and Milla Pharms. and is included in twenty NDAs.
The generic ingredient in MAGNESIUM is magnesium sulfate. There are one hundred and forty-six drug master file entries for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the magnesium sulfate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Magnesium
A generic version of MAGNESIUM was approved as magnesium sulfate by FRESENIUS KABI USA on September 8th, 1986.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for MAGNESIUM?
- What are the global sales for MAGNESIUM?
- What is Average Wholesale Price for MAGNESIUM?
Summary for MAGNESIUM
| US Patents: | 0 |
| Applicants: | 11 |
| NDAs: | 20 |
| Drug Prices: | Drug price information for MAGNESIUM |
| Drug Sales Revenues: | Drug sales revenues for MAGNESIUM |
| DailyMed Link: | MAGNESIUM at DailyMed |
US Patents and Regulatory Information for MAGNESIUM
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hq Spclt Pharma | MAGNESIUM SULFATE IN PLASTIC CONTAINER | magnesium sulfate | INJECTABLE;INJECTION | 207350-005 | Dec 6, 2017 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Hospira | MAGNESIUM SULFATE IN PLASTIC CONTAINER | magnesium sulfate | INJECTABLE;INJECTION | 020309-003 | Jan 26, 2007 | AP | RX | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Mylan Labs Ltd | MAGNESIUM SULFATE IN PLASTIC CONTAINER | magnesium sulfate | INJECTABLE;INJECTION | 209911-001 | Sep 14, 2018 | AP | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
